# Evaluation of the GORE TIGRIS Vascular Stent

Study · id `cardio:ct-nct01576055` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01576055](<https://clinicaltrials.gov/study/NCT01576055>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01576055

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 267 participants.

## Technical summary

Registry record NCT01576055. Randomized; no masking; primary purpose treatment. Start 2012-04 (registry gives no type); primary completion 2015-08 (actual). Results posted on 2016-10-19.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 267 participants (enrolled count; ClinicalTrials.gov record NCT01576055, source copy `cardio:ctgov-nct01576055-2017-10-09`, retrieved 2026-10-31)
- Start date: 2012-04 (registry gives no type) (ClinicalTrials.gov record NCT01576055, source copy `cardio:ctgov-nct01576055-2017-10-09`, retrieved 2026-10-31)
- Primary completion: 2015-08 (actual) (ClinicalTrials.gov record NCT01576055, source copy `cardio:ctgov-nct01576055-2017-10-09`, retrieved 2026-10-31)
- Completion: 2017-08 (actual) (ClinicalTrials.gov record NCT01576055, source copy `cardio:ctgov-nct01576055-2017-10-09`, retrieved 2026-10-31)
- Results first posted: 2016-10-19 (ClinicalTrials.gov record NCT01576055, source copy `cardio:ctgov-nct01576055-2017-10-09`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT01576055, source copy `cardio:ctgov-nct01576055-2017-10-09`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01576055-2017-10-09`, retrieved 2026-10-31)

## The registry's words

- Brief title: Evaluation of the GORE TIGRIS Vascular Stent
- Acronym: TIGRIS
- Condition: Peripheral Arterial Disease
- Intervention (Device): TIGRIS Vascular Stent
- Intervention (Device): BARD LifeStent
- Lead sponsor: W.L.Gore & Associates
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: W.L.Gore & Associates (`cardio:org-w-l-gore-associates`)

## Provenance

Content hash: c2207772a682ba36d246fbd4877bd7f5b65810422348bd8901138534d375f582
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
